NCCN 2012 Congress Webinar Series: Gastrointestinal Cancers™: Treatment of Localized Colon Cancer

December 19, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the current management strategies for locoregional colon cancer
  • State the selection criteria used to choose optimal therapy for patients with various stages of localized colon cancer
Additional information
Supporters: 

This activity is supported by an educational donation provided by Amgen.
This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Lilly USA, LLC; and Pfizer.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
12/19/2012
Course expires: 
03/11/2013
Event starts: 
12/19/2012 - 11:00am EST
Event ends: 
12/19/2012 - 12:00pm EST
Cost:
$0.00

John M. Skibber, MD
The University of Texas MD Anderson Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.